In this week’s edition of InnovationRx, we look at the Administration’s latest demands on drug pricing, a biotech entrepreneur treating a rare genetic disease, new technology aimed at ending drug testing on animals and more. To get it in your inbox, subscribe here . Getty

O ver the weekend , President Trump told reporters that his administration had cut drug prices “1500%.” On Sunday he walked back this claim to say that it would happen in the future, despite the fact that this is a mathematical impossibility, unless the Administration were to somehow get drug companies to pay patients to use their products.

Still, Trump’s threats on drug prices have gotten louder. On Friday, the White House sent letters to 17 pharmaceutical companies, including AbbVie, Pfizer, Novo Nordisk

See Full Page